Americans should find it easier to quit smoking following a
recommendation by the U.S. Food and Drug Administration regarding
over the counter Nicotine Replacement Therapy (NRT).
The FDA has recommended that those keen to quit smoking can
now opt for the over the counter NRT on the day they chose to
quit smoking even if it is not immediate.
The over the counter NRTs usually comes in the form of gum,
lozenge or patch. Although previously the products could not be
used for more than 12 days, the modification of the rule by FDA
allows users to do so now.
Nicotine is addictive and has been tied to cardiovascular
problems, high blood pressure and diabetes. But unlike tobacco,
it hasn't been linked to cancer.
The recommendation is expected to boost sales of NRTs. Tobacco
giants who are putting more and more focus on alternate tobacco
products will benefit from this move. Tobacco companies have to
turn to alternate harmless tobacco products as per the evolving
In accordance with such needs,
Reynolds American Inc.
) has developed a nicotine replacement therapy. The Zonnic gum
brought into the market by the company is different from the
other nicotine gums existing in the market as they are similar to
cigarettes in many ways. Zonnic does not pass on the harmful
effect of tobacco to its users. The idea seems to be supportive
to the consumers who are trying to quit cigarettes
Moreover, in May, 2012,
Altria Group Inc.
) introduced a non-dissolving, lozenge-shaped nicotine disc
called Verve - a mint-flavored disc that provides nicotine
extracted from tobacco. The other tobacco giant
Philip Morris International
) have purchased the patent and global rights to an aerosol
nicotine-delivery system. It will develop the aerosol technology
into a smokeless product that it says could be less harmful than
The recommendation is another step forward in FDA's anti
smoking campaign. The FDA is committed to reduction of cigarette
smoking in the U.S. with its stronger anti smoking campaigns. The
watchdog has designed warning labels with graphic design of a
dead body, cancerous lungs and rotten teeth to be used on
cigarette packets. It is intended to scare tobacco lovers each
time they pick up a packet of their favorite brand.
Tobacco biggies are worried about the anti-smoking campaigns
of FDA. Five tobacco giants across the globe have registered a
protest against the forceful use of such graphic labels on the
cigarette packets. Reynolds American Inc.,
), Ligget Group, Santa Fe Natural Tobacco, and Commonwealth
Brands have gone to the extent of filing a case against FDA for
imposing labels that are intend to reduce smokers rather than
helping consumers make a free choice.
While Altria and Lorillard hold a Zacks Rank #2 (Buy),
Reynolds America and Philip Morris International hold a Zacks
Rank #3 (Hold).
LORILLARD CO (LO): Free Stock Analysis Report
ALTRIA GROUP (MO): Free Stock Analysis Report
PHILIP MORRIS (PM): Free Stock Analysis
REYNOLDS AMER (RAI): Free Stock Analysis
To read this article on Zacks.com click here.